Amylin, Hoechst Marion Roussel Inc. deal

AMLN acquired exclusive rights from HMR to a series of phenolic antioxidant compounds that may

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE